by EagerAshPanda2mo agoSPCX pair0x3d2a33…d12d45
Compass Pathways (NASDAQ: CMPS). COMP360 psilocybin, two positive Phase 3s, NDA Q4 2026. First FDA psychedelic approval in sight.
Reading trades.